These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23209572)

  • 1. Exploration of lipid metabolism in relation with plasma membrane properties of Duchenne muscular dystrophy cells: influence of L-carnitine.
    Le Borgne F; Guyot S; Logerot M; Beney L; Gervais P; Demarquoy J
    PLoS One; 2012; 7(11):e49346. PubMed ID: 23209572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the organic cation/carnitine transporter family (Octn1,-2 and-3) in mdx muscle and heart: Implications for early carnitine therapy in Duchenne muscular dystrophy to improve cellular carnitine homeostasis.
    Lamhonwah AM; Tein I
    Clin Chim Acta; 2020 Jun; 505():92-97. PubMed ID: 32070725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
    Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
    Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study.
    Sharma U; Atri S; Sharma MC; Sarkar C; Jagannathan NR
    Magn Reson Imaging; 2003 Feb; 21(2):145-53. PubMed ID: 12670601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis.
    Xu H; Cai X; Xu K; Wu Q; Xu B
    Orphanet J Rare Dis; 2023 Sep; 18(1):273. PubMed ID: 37670327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.
    Capitanio D; Moriggi M; Torretta E; Barbacini P; De Palma S; Viganò A; Lochmüller H; Muntoni F; Ferlini A; Mora M; Gelfi C
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):547-563. PubMed ID: 31991054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered long chain fatty acids composition in Duchenne muscular dystrophy erythrocytes.
    Piperi C; Papapanagiotou A; Kalofoutis C; Zisaki K; Michalaki V; Tziraki A; Kalofoutis A
    In Vivo; 2004; 18(6):799-802. PubMed ID: 15646823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy.
    Nghiem PP; Bello L; Stoughton WB; López SM; Vidal AH; Hernandez BV; Hulbert KN; Gourley TR; Bettis AK; Balog-Alvarez CJ; Heath-Barnett H; Kornegay JN
    Yale J Biol Med; 2017 Sep; 90(3):351-360. PubMed ID: 28955176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
    Fallon JR; McNally EM
    Matrix Biol; 2018 Aug; 68-69():616-627. PubMed ID: 29481844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene.
    Hoffman EP
    FEBS J; 2020 Sep; 287(18):3879-3887. PubMed ID: 32608079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.
    Mah JK
    Methods Mol Biol; 2018; 1687():3-17. PubMed ID: 29067652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy.
    Pellegrini C; Zulian A; Gualandi F; Manzati E; Merlini L; Michelini ME; Benassi L; Marmiroli S; Ferlini A; Sabatelli P; Bernardi P; Maraldi NM
    J Cell Physiol; 2013 Jun; 228(6):1323-31. PubMed ID: 23169061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
    Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
    Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of fatty acid binding proteins in muscular dystrophy.
    Dowling P; Gargan S; Zweyer M; Swandulla D; Ohlendieck K
    Expert Rev Proteomics; 2020 Feb; 17(2):137-148. PubMed ID: 32067530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.